All 2,383 procedure codes billed by Medicaid providers in Puerto Rico, ranked by total spending.
| # | Code | Description | Total Paid |
|---|---|---|---|
| 1 | 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | $136.36M |
| 2 | L8699 | Prosthetic implant, not otherwise specified | $104.83M |
| 3 | J9271 | Injection, pembrolizumab, 1 mg | $101.55M |
| 4 | 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | $70.57M |
| 5 | 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | $60.59M |
| 6 | D1110 | Prophylaxis - adult | $52.35M |
| 7 | J9035 | Injection, bevacizumab, 10 mg | $51.85M |
| 8 | 84443 | Thyroid stimulating hormone (TSH) | $50.92M |
| 9 | 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | $48.34M |
| 10 | 80061 | Lipid panel | $43.08M |
| 11 | 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | $41.32M |
| 12 | 88305 | Level IV - Surgical pathology, gross and microscopic examination | $40.37M |
| 13 | 99283 | Emergency department visit for the evaluation and management, moderate severity | $39.45M |
| 14 | G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | $38.20M |
| 15 | 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | $38.09M |
| 16 | 97533 | $38.09M | |
| 17 | 99233 | Prolong inpt eval add15 m | $37.17M |
| 18 | A9276 | Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply | $36.67M |
| 19 | 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | $34.76M |
| 20 | 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | $34.53M |
| 21 | 80053 | Comprehensive metabolic panel | $33.63M |
| 22 | D1999 | $33.39M | |
| 23 | J9299 | Injection, nivolumab, 1 mg | $32.10M |
| 24 | S9123 | Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used) | $31.61M |
| 25 | A0110 | Non-emergency transportation and bus, intra or inter state carrier | $28.54M |
| 26 | 99232 | Subsequent hospital care, per day, moderate complexity | $27.52M |
| 27 | 99284 | Emergency department visit for the evaluation and management, high severity | $27.37M |
| 28 | 76641 | $26.62M | |
| 29 | J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | $26.33M |
| 30 | 77067 | Screening mammography, bilateral, including computer-aided detection | $26.06M |
| 31 | A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | $25.45M |
| 32 | J9306 | Injection, pertuzumab, 1 mg | $25.23M |
| 33 | 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | $23.61M |
| 34 | 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | $23.36M |
| 35 | D0120 | Periodic oral evaluation - established patient | $22.79M |
| 36 | 99051 | $21.83M | |
| 37 | 99223 | Prolong inpt eval add15 m | $21.57M |
| 38 | 74176 | Computed tomography, abdomen and pelvis; without contrast material | $18.63M |
| 39 | 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | $18.52M |
| 40 | D0272 | Bitewings - two radiographic images | $18.20M |
| 41 | S9097 | Home visit for wound care | $17.51M |
| 42 | 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | $17.34M |
| 43 | 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | $17.32M |
| 44 | 92002 | $17.04M | |
| 45 | 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | $16.88M |
| 46 | 92015 | Determination of refractive state | $16.83M |
| 47 | 83036 | Hemoglobin; glycosylated (A1C) | $16.44M |
| 48 | D0150 | Comprehensive oral evaluation - new or established patient | $16.42M |
| 49 | Q0084 | Chemotherapy administration by infusion technique only, per visit | $16.28M |
| 50 | 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | $15.96M |
| 51 | 92526 | $15.88M | |
| 52 | A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | $14.86M |
| 53 | 99234 | $14.73M | |
| 54 | 97032 | $14.59M | |
| 55 | 77066 | Tomosynthesis, mammo | $14.55M |
| 56 | 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | $14.04M |
| 57 | 76700 | Ultrasound, abdominal, real time with image documentation; complete | $13.72M |
| 58 | 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | $13.70M |
| 59 | D0330 | Panoramic radiographic image | $13.67M |
| 60 | 99235 | $13.50M | |
| 61 | 88312 | $13.26M | |
| 62 | J9312 | Injection, rituximab, 10 mg | $13.01M |
| 63 | 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | $12.94M |
| 64 | D1208 | Topical application of fluoride, excluding varnish | $12.94M |
| 65 | 88142 | $12.86M | |
| 66 | J0897 | Injection, denosumab, 1 mg | $12.71M |
| 67 | 88341 | $12.67M | |
| 68 | 99215 | Prolong outpt/office vis | $12.36M |
| 69 | 74177 | Computed tomography, abdomen and pelvis; with contrast material | $11.97M |
| 70 | 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | $11.96M |
| 71 | 99070 | $11.69M | |
| 72 | A0425 | Ground mileage, per statute mile | $11.56M |
| 73 | 93458 | $11.47M | |
| 74 | D2150 | Silver amalgam - two surfaces, primary or permanent | $11.46M |
| 75 | J0178 | Injection, aflibercept, 1 mg | $11.23M |
| 76 | G0299 | Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes | $11.05M |
| 77 | 76830 | Ultrasound, transvaginal | $10.39M |
| 78 | 70450 | Computed tomography, head or brain; without contrast material | $10.04M |
| 79 | 99222 | Initial hospital care, per day, moderate complexity | $10.00M |
| 80 | D1120 | Prophylaxis - child | $9.92M |
| 81 | S9083 | Global fee urgent care centers | $9.89M |
| 82 | D7240 | Removal of impacted tooth - completely bony | $9.83M |
| 83 | 88307 | $9.64M | |
| 84 | S9126 | Hospice care, in the home, per diem | $9.59M |
| 85 | 82274 | $9.42M | |
| 86 | 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | $9.38M |
| 87 | 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | $9.30M |
| 88 | 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | $9.04M |
| 89 | 93000 | $8.81M | |
| 90 | 81000 | $8.47M | |
| 91 | 78816 | $8.41M | |
| 92 | D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | $8.22M |
| 93 | 97035 | $8.06M | |
| 94 | 76536 | $7.99M | |
| 95 | 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | $7.80M |
| 96 | 97124 | $7.74M | |
| 97 | J9358 | Injection, fam-trastuzumab deruxtecan-nxki, 1 mg | $7.68M |
| 98 | D7140 | Extraction, erupted tooth or exposed root | $7.53M |
| 99 | 77386 | $7.53M | |
| 100 | 71046 | Radiologic examination, chest; 2 views | $7.30M |
| 101 | 88342 | $7.29M | |
| 102 | 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | $7.21M |
| 103 | 96160 | $7.18M | |
| 104 | 97602 | $7.08M | |
| 105 | 36415 | Collection of venous blood by venipuncture | $6.90M |
| 106 | A9277 | Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system | $6.83M |
| 107 | 86738 | $6.74M | |
| 108 | 87536 | $6.72M | |
| 109 | 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | $6.67M |
| 110 | 86328 | $6.54M | |
| 111 | 45380 | Colonoscopy, flexible; with biopsy, single or multiple | $6.52M |
| 112 | D0230 | Intraoral - periapical each additional radiographic image | $6.45M |
| 113 | D2140 | $6.35M | |
| 114 | J9022 | Injection, atezolizumab, 10 mg | $6.35M |
| 115 | 90832 | Psychotherapy, 30 minutes with patient | $6.34M |
| 116 | E0784 | External ambulatory infusion pump, insulin | $6.31M |
| 117 | 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | $6.29M |
| 118 | 67028 | Intravitreal injection of a pharmacologic agent | $6.22M |
| 119 | T1030 | Nursing care, in the home, by registered nurse, per diem | $6.17M |
| 120 | U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | $6.00M |
| 121 | 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | $5.99M |
| 122 | A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | $5.98M |
| 123 | 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | $5.82M |
| 124 | 99221 | $5.80M | |
| 125 | 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | $5.74M |
| 126 | 97530 | Therapeutic activities, direct patient contact, each 15 minutes | $5.69M |
| 127 | J2777 | Injection, faricimab-svoa, 0.1 mg | $5.68M |
| 128 | 99238 | Hospital discharge day management, 30 minutes or less | $5.67M |
| 129 | 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | $5.48M |
| 130 | A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | $5.41M |
| 131 | 84439 | $5.37M | |
| 132 | 84153 | $5.28M | |
| 133 | 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | $5.28M |
| 134 | 80048 | Basic metabolic panel (calcium, ionized) | $5.27M |
| 135 | 96415 | $5.17M | |
| 136 | S9131 | Physical therapy; in the home, per diem | $5.04M |
| 137 | 99205 | Prolong outpt/office vis | $4.93M |
| 138 | 87590 | $4.93M | |
| 139 | A4230 | Infusion set for external insulin pump, non needle cannula type | $4.90M |
| 140 | 71045 | Radiologic examination, chest; single view | $4.87M |
| 141 | 80074 | $4.83M | |
| 142 | 90472 | Immunization administration, each additional vaccine (list separately) | $4.74M |
| 143 | 93224 | $4.73M | |
| 144 | 87490 | $4.67M | |
| 145 | 99236 | Prolong inpt eval add15 m | $4.67M |
| 146 | 98942 | $4.64M | |
| 147 | Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | $4.62M |
| 148 | J9055 | Injection, cetuximab, 10 mg | $4.60M |
| 149 | S9351 | Home infusion therapy, continuous or intermittent anti-emetic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and visits coded separately), per diem | $4.58M |
| 150 | A0130 | Non-emergency transportation: wheelchair van | $4.48M |
| 151 | 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | $4.43M |
| 152 | 99050 | $4.37M | |
| 153 | 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | $4.16M |
| 154 | 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | $4.14M |
| 155 | 92250 | $4.12M | |
| 156 | 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | $4.06M |
| 157 | 50590 | $4.06M | |
| 158 | J9042 | Injection, brentuximab vedotin, 1 mg | $4.04M |
| 159 | 99442 | $4.01M | |
| 160 | 82043 | $3.99M | |
| 161 | 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | $3.96M |
| 162 | 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | $3.93M |
| 163 | V2020 | Frames, purchases | $3.93M |
| 164 | T1001 | Nursing assessment / evaluation | $3.92M |
| 165 | 76770 | $3.91M | |
| 166 | J9145 | Injection, daratumumab, 10 mg | $3.85M |
| 167 | 99220 | $3.84M | |
| 168 | 81001 | $3.81M | |
| 169 | 96367 | $3.79M | |
| 170 | 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | $3.78M |
| 171 | 99441 | $3.78M | |
| 172 | 0002A | $3.74M | |
| 173 | 99243 | $3.74M | |
| 174 | 82607 | $3.73M | |
| 175 | D0220 | Intraoral - periapical first radiographic image | $3.68M |
| 176 | D9223 | Deep sedation/general anesthesia - each subsequent 15 minute increment | $3.63M |
| 177 | J9395 | Injection, fulvestrant, 25 mg | $3.61M |
| 178 | 59515 | $3.61M | |
| 179 | Q5117 | Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg | $3.59M |
| 180 | 92134 | $3.58M | |
| 181 | 93015 | $3.57M | |
| 182 | 88185 | $3.57M | |
| 183 | S9494 | Home infusion therapy, antibiotic, antiviral, or antifungal therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with home infusion codes for hourly dosing schedules s9497-s9504) | $3.55M |
| 184 | 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | $3.50M |
| 185 | J9354 | Injection, ado-trastuzumab emtansine, 1 mg | $3.49M |
| 186 | 88365 | $3.48M | |
| 187 | 87276 | $3.47M | |
| 188 | 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | $3.44M |
| 189 | D0160 | $3.43M | |
| 190 | 99219 | $3.38M | |
| 191 | 87088 | $3.37M | |
| 192 | E0465 | Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube) | $3.36M |
| 193 | 0001A | $3.31M | |
| 194 | 97161 | $3.26M | |
| 195 | A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | $3.25M |
| 196 | 90837 | Psychotherapy, 53 minutes with patient | $3.24M |
| 197 | S9560 | Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | $3.17M |
| 198 | 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | $3.14M |
| 199 | C1874 | Stent, coated/covered, with delivery system | $3.10M |
| 200 | D1351 | Sealant - per tooth | $3.06M |